Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
REDWOOD CITY, Calif., Dec. 11, 2023 -- Codexis, Inc. , a leading enzyme engineering company, hosted a virtual Key Opinion Leader event on Friday, December 8, 2023, to discuss the growth of RNA...
Codexis (NASDAQ:CDXS – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a report released on Wednesday. Several other analysts have also recently issued reports on the company. Stifel Nicolaus cut their target price on Codexis from $9.00 to $5.00 and set a “buy” rating for the company in a research report […]
Analysts’ upgrades for Wednesday, December 6th: Antero Midstream (NYSE:AM) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Ardmore Shipping (NYSE:ASC) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Codexis (NASDAQ:CDXS) was upgraded by analysts at StockNews.com to a sell rating. Chegg (NYSE:CHGG) was […]
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) was the target of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 3,110,000 shares, a growth of 12.3% from the October 31st total of 2,770,000 shares. Based on an average daily trading volume, of 846,800 shares, […]
/PRNewswire/ -- The "Biofuel Enzymes - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Biofuel...